Recent News

• 02.05.2025 - Precision BioSciences – Guggenheim SMID Cap Biotech Conference
• 01.29.2025 - Precision BioSciences Strengthens Senior Leadership Team to Drive Multiple In Vivo Gene Editing Programs
• 01.09.2025 - Precision BioSciences Announces Complete Clinical Response in First Infant Dosed by Partner iECURE in Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency

Recent Filings

• 01.29.2025 - 8-K Current report
• 01.24.2025 - 144 Report of proposed sale of securities
• 01.22.2025 - 4 Statement of changes in beneficial ownership of securities